Recent articles posted on bioRxiv* The preprint server has identified a number of effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies from convalescent SARS-CoV-2 patients....
In a recent study posted on bioRxiv* Preprint server, researchers evaluated the efficiency of lipid nanoparticles against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). study: Delivery...
Recent articles posted on bioRxiv* The preprint server analyzed a multivalent messenger ribonucleic acid (mRNA) -lipid nanoparticle (LNP) vaccine construct against a specific β-coronavirus (β-CoV). study:...
As of April 21, 2022, coronavirus 2 (SARS-CoV-2), a severe acute respiratory syndrome that causes coronavirus disease 2019 (COVID-19), has infected more than 507 million people...
Coronavirus Disease 2019 (COVID-19) was caused by infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causing a global epidemic with high morbidity and mortality. .....
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic surveillance continues to reveal a spectrum of various novel mutations with mutations in the spike gene, which encodes...
Recent Comments